Patent details

Basic Information

Publication number:

EP2332581

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP101835650

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Tri- or tetravalent meningococcal polysaccharide-CRM197 conjugate vaccine

French Title of Invention:

Vaccin de meningocoque tri- ou tetravalent préparé avec un conjugué de polysaccharide et de CRM197

German Title of Invention:

Tri- oder tetravalenter Meningokokken-Impfstoff bestehend aus einem Polysaccharid-CRM197-Konjugat

SPC Number:

Dates

Filing date:

22/01/2002

Grant date:

01/07/2015

EP Publication Date:

01/07/2015

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

15/06/2011

EP B1 Publication Date:

01/07/2015

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

22/01/2022

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

22/01/2002

 

 

Name:

Sanofi Pasteur Inc.

Address:

Discovery Drive, Swiftwater, PA 18370-0187, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

08/07/2015

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

Name:

Ryall Robert

Address:

United States (US)

Priority

Priority Number:

263435 P

Priority Date:

23/01/2001

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 47/48;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

11/01/2021

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages